| abstract |
This invention relates to newly identified HSV-2 polynucleotides, polypeptides encoded by such polynucleotides, the uses of such polynucleotides and polypeptides, as well as the production of such polynucleotides and polypeptides and recombinant host cells transformed with the polynucleotides. This invention also relates to inhibiting or activating the biosynthesis or action of such polynucleotides or polypeptides and the use of such inhibitors or activators in therapy. |